The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1040
ISSUE1040
November 20, 1998
New Drugs for Rheumatoid Arthritis
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
New Drugs for Rheumatoid Arthritis
November 20, 1998 (Issue: 1040)
Leflunomide (Arava - Hoechst Marion Roussel), which inhibits pyrimidine synthesis, and etanercept (Enbrel - Immunex/Wyeth-Ayerst), which blocks the action of tumor necrosis factor (TNF), have been approved by the FDA for treatment of rheumatoid ...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.